 |
PDBsum entry 5jw1
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
5jw1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Crystal structure of celecoxib bound to s121p murine cox-2 mutant
|
|
Structure:
|
 |
Prostaglandin g/h synthase 2. Chain: a, b. Synonym: cyclooxygenase-2,cox-2,glucocorticoid-regulated inflammatory cyclooxygenase,gripghs,macrophage activation-associated marker protein p71/73,pes-2,phs ii,prostaglandin h2 synthase 2,pghs-2, prostaglandin-endoperoxide synthase 2,tis10 protein. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Mus musculus. Mouse. Organism_taxid: 10090. Gene: ptgs2, cox-2, cox2, pghs-b, tis10. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
|
|
Resolution:
|
 |
|
2.82Å
|
R-factor:
|
0.191
|
R-free:
|
0.226
|
|
|
Authors:
|
 |
M.G.Malkowski,B.J.Orlando
|
|
Key ref:
|
 |
L.Dong
et al.
(2016).
Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.
J Biol Chem,
291,
25641-25655.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-May-16
|
Release date:
|
26-Oct-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q05769
(PGH2_MOUSE) -
Prostaglandin G/H synthase 2 from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
604 a.a.
552 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.99.1
- prostaglandin-endoperoxide synthase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + 2 O2 = prostaglandin H2 + A + H2O
|
 |
 |
 |
 |
 |
(5Z,8Z,11Z,14Z)-eicosatetraenoate
|
+
|
AH2
|
+
|
2
×
O2
|
=
|
prostaglandin H2
|
+
|
|
+
|
H2O
Bound ligand (Het Group name = )
matches with 51.11% similarity
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
291:25641-25655
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.
|
|
L.Dong,
C.Yuan,
B.J.Orlando,
M.G.Malkowski,
W.L.Smith.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Prostaglandin endoperoxide H synthase-2 (PGHS-2), also called cyclooxygenase-2
(COX-2), converts arachidonic acid to PGH2 PGHS-2 is a conformational
heterodimer composed of allosteric (Eallo) and catalytic
(Ecat) subunits. Fatty acids (FAs) bind to Arg-120 of
Eallo increasing to different degrees, depending on the FA, the
Vmax of its Ecat partner. We report here that movement of
helical residues 120-122 and loop residues 123-129 of Eallo underlies
the allosteric effects of FAs and allosteric COX-2 inhibitors, including
naproxen and flurbiprofen. An S121P substitution in both PGHS-2 monomers yields
a variant (S121P/S121P PGHS-2) that has 1.7-1.8 times the Vmax of
native PGHS-2 and is relatively insensitive to activation by FAs or inhibition
by allosteric inhibitors. The S121P substitution in Eallo is
primarily responsible for these effects. In X-ray crystal structures, the Cα
atoms of helical residues 119-122 of S121P/S121P PGHS-2 are displaced from their
normal positions. Additionally, the S121P/S121P PGHS-2 variants in which Pro-127
and Ser-541 are replaced by cysteines spontaneously forms Cys-127 to Cys-541
cross-links between monomers. This is unlike the corresponding native PGHS-2
variant and suggests that S121P substitutions also unhinge the loop involving
residues 123-129. We conclude the following: (a) the region involving residues
120-129 of unoccupied Eallo tonically inhibits Ecat; (b)
binding of an activating FA (e.g. arachidonic, palmitic, or oleic acid) to
Eallo or an S121P substitution in Eallo repositions this
region to increase Ecat activity; and (c) allosteric COX inhibitors
act by preventing FA binding to Eallo and additionally by relocating
Eallo residues to inhibit Ecat.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |